Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : Yesterday    sector : Health technology    save search
Opthea to Present at the OIS Retina Innovation Summit at ARVO
Published: 2024-04-25 (Just crawled : 13:00) - globenewswire.com
OPT | News | $3.43 2.08% 2.89% 0 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
innovation retina
BioCardia Completes Enrollment of CardiAMP Cell Therapy for the Treatment of Chronic Myocardial Ischemia Trial Open Label Roll-In Cohort
Published: 2024-04-25 (Just crawled : 13:00) - globenewswire.com
BCDA P | $0.3795 0.93% -2.56% 220 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
label cell treatment for cardiamp trial therapy
INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Published: 2024-04-25 (Just crawled : 13:00) - globenewswire.com
INMB | News 0 d | $10.62 4.73% 4.38% 0 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
nasdaq million direct offering
Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results
Published: 2024-04-25 (Crawled : 12:00) - globenewswire.com
MEDE | $0.51 0% 500 twitter stocktwits trandingview |
n/a
 | Email alert Add to watchlist
PBH | $70.13 -1.53% 0.0% 0 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
results
Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11
Published: 2024-04-25 (Crawled : 12:00) - globenewswire.com
VERU | $1.33 0.76% 26K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
association meeting
Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024
Published: 2024-04-25 (Crawled : 12:00) - globenewswire.com
FBIO | $1.79 -1.11% -1.4% 0 twitter stocktwits trandingview |
Health Technology
 | | O: -2.23% H: 0.0% C: 0.0%
corporation microcap medical
Aligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A. Harrison, MD
Published: 2024-04-25 (Crawled : 12:00) - globenewswire.com
ALGS | $0.829 0.66% -0.39% 220 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
therapeutics
MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences
Published: 2024-04-25 (Crawled : 12:00) - globenewswire.com
MDWD | $17.59 7.19% 6.44% 210 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
escharex care
Collegium to Report First Quarter 2024 Financial Results on May 9, 2024
Published: 2024-04-25 (Crawled : 12:00) - globenewswire.com
COLL | $35.48 -1.28% -1.27% 88 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
first report financial results
Assertio Holdings, Inc. to Report First Quarter 2024 Financial Results on May 6, 2024
Published: 2024-04-25 (Crawled : 12:00) - globenewswire.com
ASRT | $0.8656 -4.83% -5.63% 260 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
first report financial results
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
Published: 2024-04-25 (Crawled : 12:00) - biospace.com/
TSVT | $3.87 -9.37% 87K twitter stocktwits trandingview |
| | O: -7.96% H: 0.0% C: 0.0%
BMY | $46.72 -4.38% 2M twitter stocktwits trandingview |
Health Technology
 | | O: -2.95% H: 0.0% C: 0.0%
first for financial results
ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
Published: 2024-04-25 (Crawled : 12:00) - globenewswire.com
PRPH | $5.06 -1.94% -0.78% 0 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
microcap
Long-term Complete Response to Can-Fite's Namodenoson in Patient with Advanced Liver Cancer: Article Published in a Leading Scientific Journal
Published: 2024-04-25 (Crawled : 12:00) - biospace.com/
CANF | $1.94 2.7K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
liver namodenoson advanced response journal publication
UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting
Published: 2024-04-25 (Crawled : 12:00) - globenewswire.com
UBX | $1.47 1.5K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
meeting
BioVie Presents Data Showing Potential for Bezisterim (NE3107) to Reduce Inflammation and Restore Homeostasis in a Manner Correlated with Alzheimer’s Disease and Biomarker Endpoints
Published: 2024-04-25 (Crawled : 12:00) - globenewswire.com
BIVI | $0.4824 -4.55% 370K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
ne3107 disease biomarker alzheimer’s bezisterim
Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024
Published: 2024-04-25 (Crawled : 12:00) - globenewswire.com
ACHV | $4.54 0.89% 0.66% 0 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
first conference life sciences financial results
Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8:00 a.m. ET
Published: 2024-04-25 (Crawled : 12:00) - globenewswire.com
AQST | $3.9 -8.88% -9.6% 33K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
first conference report business therapeutics financial results
Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress
Published: 2024-04-25 (Crawled : 12:00) - biospace.com/
MRNA | News S | $108.85 0.89% 0.85% 23K twitter stocktwits trandingview |
Health Technology
 | | O: -3.3% H: 0.0% C: 0.0%
congress respiratory cytomegalovirus research global
Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024
Published: 2024-04-25 (Crawled : 12:00) - biospace.com/
HROW P | $10.27 -0.48% -0.44% 37 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
first financial results market
Aldeyra Therapeutics Highlights Recent Preclinical Data in Obesity, Atopic Dermatitis, Pain, and Alcoholic Hepatitis, and Announces Planned Pivotal Clinical Trial in Retinitis Pigmentosa, at 2024 Research & Development Day
Published: 2024-04-25 (Crawled : 12:00) - biospace.com/
ALDX | $3.89 -1.27% 66K twitter stocktwits trandingview |
Health Technology
 | | O: -1.63% H: 0.0% C: 0.0%
day research preclinical trial therapeutics development
Gainers vs Losers
50% 50%

Top 10 Gainers
CSSE 4 | $0.299 96.32% 7M twitter stocktwits trandingview |
Consumer Services
BRFH 4 | $1.99 80.91% 13M twitter stocktwits trandingview |
Manufacturing
BOF | $1.915 63.68% 620K twitter stocktwits trandingview |

ACON | $0.3595 24.83% 3.5M twitter stocktwits trandingview |
n/a
CDTX | News | $14.57 18.55% 330K twitter stocktwits trandingview |
Health Technology
ULBI M | $10.12 15.92% 120K twitter stocktwits trandingview |
Producer Manufacturing
LRHC | $1.79 11.88% 3K twitter stocktwits trandingview |
n/a
TRU | $74.475 8.44% 100K twitter stocktwits trandingview |
Technology Services
BQ | $0.279 7.31% 14K twitter stocktwits trandingview |
Consumer Non-Durables
CASI | $2.61 6.97% 13K twitter stocktwits trandingview |
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.